Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • CDIX program makes alerts more meaningful

    Electronic drug interaction alerts can be useful in preventing harmful drug-drug interactions, but too many clinically insignificant alerts can lead to "alert fatigue" and clinically significant alerts may be overridden.
  • Drug Criteria & Outcomes: New FDA Approvals

    FDA recently announced these approvals: Biogen Idec's Tysabri® (natalizumab) has been approved by FDA for treating moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to or are unable to tolerate conventional Crohn's disease therapies.
  • Caution when starting statins in high-risk patients

    Research at the University of Mississippi Medical Center indicating that statin therapy reduces risk of developing all cerebrovascular events (CVE) and ischemic stroke, but is associated with a nonsignificant increase in risk of hemorrhagic stroke, is not likely to cause a major change in medical practice.
  • Transitioning patients from clinic to physician-managed care didn't work

    What do you do when your successful hospital-based anticoagulation clinic has more patients than available slots? Detroit Medical Center pharmacist Candice Garwood, PharmD, faced that situation about three years ago and tells Drug Formulary Review she thought she had come up with a workable solutiontransition the most stable patients from the pharmacist-managed clinic to their physicians to continue their anticoagulation care.
  • News Brief

    Following the deaths of two patients at specialty hospitals owned by physicians in both cases, the patients suffered complications following surgery, no physician was on duty, and the specialty hospitals called 9-1-1 to respond the Senate Finance Committee asked the Office of Inspector General (OIG) to evaluate patient care at 109 physician-owned specialty hospitals in the United States, and the OIG report, released in January, has raised concerns for patient safety.
  • Ethics center to standardize ethics consultations

    The U.S. Veterans Health Administration (VA) National Center for Ethics in Health Care launched a major ethics integration initiative in 2007, including a new component that seeks to standardize and evaluate the quality of ethics consultations.
  • Know risks of restraint with violent patients

    After an intoxicated and combative man broke loose from restraints, he struck two ED nurses and threw a computer at another nurse at a New York hospital in December 2007. Could this happen at your ED?
  • White ED patients more likely to get narcotics

    White ED patients are more likely to receive narcotics such as oxycodone and morphine than patients of other races or ethnicities, says a new study.
  • Adverse effects from ED sedation are common

    When children have procedural sedation in the ED, at least 42% have at least one adverse effect, according to a recent study of 547 children.
  • Full March 2008 Issue in PDF